Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Scheiblhofer

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Methods (San Diego, Calif.)|February 14, 2004
DNA vaccines for allergy treatmentArnulf Hartl, Richard Weiss, Romana Hochreiter, et al.
Current Opinion in Allergy and Clinical Immunology|September 22, 2010
Prophylactic mRNA vaccination against allergyRichard Weiss, Sandra Scheiblhofer, Elisabeth Roesler, et al.
Expert Review of Vaccines|December 14, 2011
mRNA vaccination as a safe approach for specific protection from type I allergyRichard Weiss, Sandra Scheiblhofer, Elisabeth Roesler, et al.
Expert Review of Vaccines|March 15, 2017
Influence of protein fold stability on immunogenicity and its implications for vaccine designSandra Scheiblhofer, Josef Laimer, Yoan Machado, et al.
Methods in Molecular Medicine|September 22, 2006
Replicase-based DNA vaccines for allergy treatmentSandra Scheiblhofer, Richard Weiss, Maximilian Gabler, et al.
International Journal of Pharmaceutics|December 5, 2020
Functionalized multifunctional nanovaccine for targeting dendritic cells and modulation of immune responseNesma El-Sayed, Evgeniia Korotchenko, Sandra Scheiblhofer, et al.
Vaccine|August 7, 2002
Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccinesRichard Weiss, Sandra Scheiblhofer, Johann Freund, et al.
Frontiers in Cellular Neuroscience|July 23, 2016
Allergy Enhances Neurogenesis and Modulates Microglial Activation in the HippocampusBarbara Klein, Heike Mrowetz, Josef Thalhamer, et al.
Vaccine|August 8, 2021
Laser facilitated epicutaneous peptide immunization using dry patch technologySandra Scheiblhofer, Stephan Drothler, Werner Braun, et al.
Vaccine|July 6, 2021
Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 bindingSandra Scheiblhofer, Stephan Drothler, Werner Braun, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Methods (San Diego, Calif.)|February 14, 2004
DNA vaccines for allergy treatmentArnulf Hartl, Richard Weiss, Romana Hochreiter, et al.
Current Opinion in Allergy and Clinical Immunology|September 22, 2010
Prophylactic mRNA vaccination against allergyRichard Weiss, Sandra Scheiblhofer, Elisabeth Roesler, et al.
Expert Review of Vaccines|December 14, 2011
mRNA vaccination as a safe approach for specific protection from type I allergyRichard Weiss, Sandra Scheiblhofer, Elisabeth Roesler, et al.
Expert Review of Vaccines|March 15, 2017
Influence of protein fold stability on immunogenicity and its implications for vaccine designSandra Scheiblhofer, Josef Laimer, Yoan Machado, et al.
Methods in Molecular Medicine|September 22, 2006
Replicase-based DNA vaccines for allergy treatmentSandra Scheiblhofer, Richard Weiss, Maximilian Gabler, et al.
International Journal of Pharmaceutics|December 5, 2020
Functionalized multifunctional nanovaccine for targeting dendritic cells and modulation of immune responseNesma El-Sayed, Evgeniia Korotchenko, Sandra Scheiblhofer, et al.
Vaccine|August 7, 2002
Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccinesRichard Weiss, Sandra Scheiblhofer, Johann Freund, et al.
Frontiers in Cellular Neuroscience|July 23, 2016
Allergy Enhances Neurogenesis and Modulates Microglial Activation in the HippocampusBarbara Klein, Heike Mrowetz, Josef Thalhamer, et al.
Vaccine|August 8, 2021
Laser facilitated epicutaneous peptide immunization using dry patch technologySandra Scheiblhofer, Stephan Drothler, Werner Braun, et al.
Vaccine|July 6, 2021
Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 bindingSandra Scheiblhofer, Stephan Drothler, Werner Braun, et al.
Pageof 7